Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $.001 per share
-
Shares outstanding
-
10,535,714
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
1,389,594
-
Shares change
-
+1,200,110
-
Total reported value, excl. options
-
$1,611,511
-
Value change
-
+$1,371,542
-
Number of buys
-
16
-
Number of sells
-
-5
-
Price
-
$1.16
Significant Holders of SOLIGENIX, INC. - Common Stock, par value $.001 per share (SNGX) as of Q3 2025
24 filings reported holding SNGX - SOLIGENIX, INC. - Common Stock, par value $.001 per share as of Q3 2025.
SOLIGENIX, INC. - Common Stock, par value $.001 per share (SNGX) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,389,594 shares
of 10,535,714 outstanding shares and own 13% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (708,000 shares), DRW Securities, LLC (171,422 shares), TWO SIGMA INVESTMENTS, LP (87,646 shares), SABBY MANAGEMENT, LLC (81,000 shares), RENAISSANCE TECHNOLOGIES LLC (72,900 shares), HRT FINANCIAL LP (54,669 shares), VANGUARD GROUP INC (52,522 shares), Virtu Financial LLC (50,864 shares), Banco BTG Pactual S.A. (46,372 shares), and GEODE CAPITAL MANAGEMENT, LLC (42,590 shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.